Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Ascentage Pharma Group International (AAPG : NSD)

Sector: Healthcare

Close
(03-20-2026)
$19.11
Change
-$2.93 (-13.29%)
Volume 17,597
Open $21.00
Day Range $19.11 - $21.00
52 Week Low $17.56
52 Week High $48.45
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $1,663,843,586
Shares Outstanding 87,066,645
Book Value per Share $6.31
Earnings per Share -$0.73
Period
Loading......
Loading......

Legend

Ascentage Pharma Group International

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
March 20, 2026 19.11
-$2.93 (-13.29%)
March 19, 2026 22.04
-$2.01 (-8.36%)
March 18, 2026 24.05
-$0.35 (-1.43%)
March 17, 2026 24.40
-$0.11 (-0.45%)
March 16, 2026 24.51
$0.08 (0.33%)
March 13, 2026 24.43
$0.43 (1.79%)
March 12, 2026 24.00
-$0.22 (-0.91%)
March 11, 2026 24.22
-$0.27 (-1.10%)
March 10, 2026 24.49
$0.80 (3.38%)
March 09, 2026 23.69
$0.55 (2.38%)
March 06, 2026 23.14
$0.83 (3.72%)
March 05, 2026 22.31
$0.06 (0.27%)
March 04, 2026 22.25
$0.61 (2.82%)
March 03, 2026 21.64
-$2.02 (-8.54%)
March 02, 2026 23.66
-$0.44 (-1.83%)
February 27, 2026 24.10
$0.00 (0.00%)
February 26, 2026 24.10
-$0.95 (-3.79%)
February 25, 2026 25.05
$0.05 (0.20%)
February 24, 2026 25.00
$0.00 (0.00%)
February 23, 2026 25.00
$0.07 (0.28%)
February 20, 2026 24.93
$1.18 (4.97%)
February 19, 2026 23.75
-$0.94 (-3.81%)
February 18, 2026 24.69
-$0.31 (-1.24%)
February 17, 2026 25.00
$1.18 (4.95%)
February 16, 2026 23.82
$0.00 (0.00%)
February 13, 2026 23.82
$0.62 (2.67%)
February 12, 2026 23.20
-$1.40 (-5.69%)
February 11, 2026 24.60
$0.60 (2.50%)
February 10, 2026 24.00
$0.39 (1.65%)
February 09, 2026 23.61
-$0.91 (-3.71%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports